Access
To read this story in full you will need to login or make a payment (see right).
Correspondence
Nature 440, 605 (30 March 2006) | doi:10.1038/440605d; Published online 29 March 2006
Open Innovation Challenges
-
Novel Approaches to Protecting Maize from Insect Damage
The Seeker is looking for novel approaches to protecting maize from insect damage. This Challenge re...
-
Methods of Modeling Adaptation in Populations
The analysis of adaptation with a population is a frequently encountered computational modeling scen...
nature jobs
Business Devlopment Officer
- Rhydburg Pharmaceuticals
- Selaqui-Dehradun India
Postdoctoral Position
- Fox Chase Cancer Center
- Philadelphia, Pennsylvania, United States, 19111
Populations who test drugs should benefit from them
Sanjay Basu1, Jason Andrews1 & Duncan Smith-Rohrberg1
- Yale University School of Medicine, 129 York Street, New Haven, Connecticut 06511, USA
Paul Herrling, in his Commentary article "Experiments in social responsibility" (Nature 439, 267–268; 2006), describes pharmaceutical companies moving towards a more progressive approach to drug development and distribution in poor countries. But it is important to note that, even when research in developing nations leads to effective treatments, there is still the danger of local populations being exploited.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Structure of the Mad2 spindle assembly checkpoint protein and its interaction with Cdc20Nature Structural Biology Article (01 Mar 2000)
Molecular mechanism of NPF recognition by EH domainsNature Structural Biology Letter (01 Nov 2000)

